This compound is primarily utilized in biochemical research as a potent and selective degrader of specific proteins. It is often employed in studies focusing on targeted protein degradation, particularly through the proteolysis-targeting chimera (PROTAC) technology. Researchers use it to investigate cellular processes, protein functions, and signaling pathways by selectively inducing the degradation of target proteins. Its application extends to drug discovery and development, where it helps in understanding the role of specific proteins in disease mechanisms and evaluating potential therapeutic targets. Additionally, it is used in studying the ubiquitin-proteasome system and its implications in various biological and pathological conditions.